Sarcoma-specific CAR-T cells
PreclinicalCell therapy
Sarcoma-specific CAR-T cells is one of 7 biologic programs targeting Sarcoma. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
8 competitors in Sarcoma
#DrugCompanyPhaseTrials
1Neulasta
AmgenPhase 3
Taxotere
AAvyxa
Phase 3
Neupogen
EEastern Cooperative Oncology Group
Phase 3
Gemzar
GGynecologic Oncology Group
Phase 3
Avastin
BBio-Thera Solutions
Phase 3
IC-Green
CCHX Technologies Inc.
Phase 2
Sarcoma-specific CAR-T cells
SShenzhen Geno-Immune Medical Institute
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details